Author:
Reddy Poli Adi Narayana,Stine Zachary,Salvino Joseph M.
Reference8 articles.
1. Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study;Pardee;Future Oncol.,2019
2. A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas;Philip;Future Oncol.,2019
3. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial;Alistar;Lancet Oncol.,2017
4. Mansour, T. S. Preparation of 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases such as cancer US 20180208584 A1.
5. Synthesis of a Cn–Cn+6 Building Block Common to Important Polyol, Polyene Antibiotics from a Divinylcarbinol by a Desymmetrizing Sharpless Epoxidation;Nachbauer;Eur. J. Org. Chem.,2013